Vincristine and Prednisolone Therapy in Blast Crisis of Chronic Myelogenous Leukaemia in Childhood
- 1 November 1981
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Haematology
- Vol. 27 (5) , 323-326
- https://doi.org/10.1111/j.1600-0609.1981.tb00492.x
Abstract
6 cases of chronic myelogenous leukaemia (CML) blast crisis in childhood were treated with vincristine and prednisolone (V‐P). In 3 terminal transferase (TdT)‐positive cases, blast cells were lymphoid in appearance. All 3 TdT‐positive patients entered a complete remission but developed meningeal leukaemia. The mean duration of survival from the onset of blast crisis was 32 months. In 3 TdT‐negative cases, V‐P therapy was ineffective. The results of this study suggest that V‐P therapy is more effective for CML blast crisis in childhood with TdT positive blast cells and that prophylactic central nervous system treatment is necessary to prevent meningeal leukaemia.Keywords
This publication has 9 references indexed in Scilit:
- Philadelphia chromosome positive childhood acute lymphoblastic leukemiaBlood, 1980
- PHILADELPHIA-CHROMOSOME POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA1980
- Chronic myelogenous leukemiaCancer, 1978
- Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1978
- Meningeal leukemia in the blastic phase of chronic granulocytic leukemiaThe American Journal of Medicine, 1975
- Blastic crisis in chronic granulocytic leukemia: Experience in 39 patientsCancer, 1974